Prodrug strategies to enhance the intestinal absorption of peptides

被引:44
作者
Gangwar, S
Pauletti, GM
Wang, BH
Siahaan, TJ
Stella, VJ
Borchardt, RT
机构
[1] PROLINX INC,BOTHELL,WA 98021
[2] N CAROLINA STATE UNIV,DEPT CHEM,RALEIGH,NC 27695
关键词
D O I
10.1016/S1359-6446(97)01011-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Clinical development of orally active peptide drugs has been restricted by the unfavorable physicochemical properties of these molecules limiting intestinal mucosal permeation and the lack of stability of peptides against enzymatic degradation. Successful oral delivery of pep tides will depend, therefore, on strategies designed to alter the physicochemical characteristics of these potential drugs,without changing their biological activity, in order to increases the permeation across intestinal cells. This manuscript will focus on the biological barrier properties that limit oral peptide bioavailabiiity and on prodrug strategies designed to overcome these barriers.
引用
收藏
页码:148 / 155
页数:8
相关论文
共 84 条
[2]   (ACYLOXY)ALKYL CARBAMATE PRODRUGS OF NORFLOXACIN [J].
ALEXANDER, J ;
FROMTLING, RA ;
BLAND, JA ;
PELAK, BA ;
GILFILLAN, EC .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (01) :78-81
[3]  
AMIDON GL, 1994, ANNU REV PHARMACOL, V34, P321
[4]   THE LACTONIZATION OF 2'-HYDROXYHYDROCINNAMIC ACID-AMIDES - A POTENTIAL PRODRUG FOR AMINES [J].
AMSBERRY, KL ;
BORCHARDT, RT .
JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (23) :5867-5877
[5]   AMINE PRODRUGS WHICH UTILIZE HYDROXY AMIDE LACTONIZATION .2. A POTENTIAL ESTERASE-SENSITIVE AMIDE PRODRUG [J].
AMSBERRY, KL ;
GERSTENBERGER, AE ;
BORCHARDT, RT .
PHARMACEUTICAL RESEARCH, 1991, 8 (04) :455-461
[6]  
ANG B, 1997, J ORG CHEM, V62, P1363
[7]  
[Anonymous], LIPOPHILICITY DRUG A
[8]  
[Anonymous], MAMMALIAN PROTEASES
[9]  
[Anonymous], 1987, Physiology of the Gastrointestinal Tract
[10]  
AUSTEL V, 1983, UANTITATIVE STRUCTUR, P437